Aveanna (AVAH): 10% owner moves <0.2% stake via Form 4 transfer
Rhea-AI Filing Summary
Form 4 filing overview: Robert M. Williams Jr., identified as a 10% owner of Aveanna Healthcare Holdings, Inc. (AVAH), reported two immaterial transactions dated 07/10/2025. Both were coded “J,” indicating in-kind distributions rather than open-market trades.
- PSA Healthcare Investment Holdings LLC distributed 64,773 AVAH common shares to its members at a stated price of $0, reducing its post-distribution position to 15,523,809 shares.
- PSA Iliad Holdings LLC similarly distributed 17,109 shares, leaving 1,426,034 shares.
No purchases were reported, and the filing shows Mr. Williams continues to hold—through multiple J.H. Whitney-related entities—approximately 51.6 million shares indirectly. There were no direct holdings and no change to the larger positions held by J.H. Whitney VII, L.P. (28.9 million shares), JHW Iliad Holdings LLC (5.18 million), or JHW Iliad Holdings II LLC (0.54 million).
Investor takeaway: The reported movements are administrative re-allocations within affiliated funds, executed at $0 and representing less than 0.2% of the insider’s aggregate indirect stake. Because no cash sales occurred and overall exposure remains essentially unchanged, the filing is neutral from a supply-demand perspective but does increase the free-float slightly as distributed shares migrate to individual members.
Positive
- None.
Negative
- Free-float may increase slightly as 81,882 shares move from fund vehicles to individual members, potentially adding minor selling pressure.
Insights
TL;DR: Very small in-kind transfers; insider’s aggregate stake intact—neutral market impact.
The Form 4 discloses two code-J distributions totaling 81,882 shares (<0.2% of the insider’s indirect holdings). Such transfers usually reflect fund-level liquidity events or investor redemptions and do not signal management sentiment. With no cash proceeds and no change to the major 28.9 million and 15.5 million share blocks, selling pressure is unlikely. However, once distributed, shares could be sold by underlying members, marginally lifting float. Overall, the filing lacks material financial implications for AVAH.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock, $0.01 par value | 64,773 | $0.00 | $0.00 |
| Other | Common Stock, $0.01 par value | 17,109 | $0.00 | $0.00 |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Footnotes (6)
- F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F4. Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F5. In-kind distribution from PSA Healthcare to its members.
- F6. In-kind distribution from PSA Iliad Holdings to its members.
AI-generated analysis. How Rhea-AI works. Not financial advice.
